title: Pyruvate kinase deficiency and delayed clinical response to recombinant human erythropoietin treatment.
authors.forename: P
authors.initials: P
authors.lastname: Zachée
authors.forename: G E
authors.initials: GE
authors.lastname: Staal
authors.forename: G
authors.initials: G
authors.lastname: Rijksen
authors.forename: R
authors.initials: R
authors.lastname: De Bock
authors.forename: M M
authors.initials: MM
authors.lastname: Couttenye
authors.forename: M E
authors.initials: ME
authors.lastname: De Broe
mesh_terms: D000328:Adult; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011770:Pyruvate Kinase / Q000172:deficiency*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D013997:Time Factors
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D011770:Pyruvate Kinase